Background: Subchondral bone cyst (SBC) formation is often identified in patients with osteoarthritis. Furthermore, several studies have shown that expression of matrix metalloproteinases (MMPs) is elevated in patients with OA. Objectives: The aim of our study is to correlate the presence of SBCs and MMP-1 expression with the osteochondral alterations during OA progression. Methods: We studied the cartilage and subchondral bone of 15 patients who had undergone total knee or hip replacement due to primary OA. As controls, we used the femoral heads of three patients without macroscopic OA changes. We evaluated three specimens per patient. Results: Specimens were divided in four groups based on the Mankin histological severity score. Using immunohistochemistry, we noted SBCs at the site of greatest disease severity. Specifically, these were present more frequently in group III (Mankin score: 6-7) and IV (Mankin: ≥ 8), compared with group I (Mankin: 1-3) and II (Mankin: 4-5). Mild OA stages (Mankin: 1-6) were characterized by degeneration and thinning of the cartilage, followed by increased osteoblast and osteoclast activity of the subjacent bone and the subsequent appearance of SBCs. Simultaneously, we observed expression of MMP-1 in groups I and II in the cartilage and III and IV in * Corresponding author. both the cartilage and the subchondral bone. Moreover, osteoblast-like cells in the lining of the SBCs showed an increased expression of MMP-1 in stages III and IV. Conclusion: Our study provides immunohistological evidence that SBCs accumulate in advanced OA and contain activated cells, which express MMP-1, suggesting that they may thus participate in the osteochondral changes of OA. Level of evidence: Level III; prospective comparative study.
Introduction
Osteoarthritis (OA) is the major cause of disability in the adult population. Although in the past it was considered as a primary disorder of articular cartilage, it is now generally considered as a disease of the whole joint, including the calcified cartilage, subchondral cortical and trabecular bone, joint capsular tissues and the synovium [1] . Not only the structural support, but also the biological cross-talk between bone and cartilage, make subchondral bone and cartilage become a closely functional unit that cannot be separated [2] . A characteristic of bone adaptation associated with OA is the presence of subchondral bone cysts (SBC) [3] that are present in about 50% of subjects with knee OA [4, 5] .
Subchondral bone cysts (SBCs), ''pseudocysts'' or ''geodes'' [6] [7] [8] , were first identified by Ondrouch [9] and Landells [10] in the load-bearing regions of the femur, patella, and shoulder of arthritic patients, although the exact cause is not well known [8] . Currently, there are two main theories: the ''Bone Contusion Theory'' where bony microcontusions below the joint surface, associated with increased intra-articular pressure lead to extension of synovial fluid into the subchondral bone through tiny gaps in the articular surface, and the ''Synovial Breach Theory'' where a breach in the subchondral plate caused by a diminished local cartilage leads to a rapid inflammation response and the proliferation of myxomatous tissue within the bone marrow [6, 8, 9, 11] . Subchondral cystic lesions appear as well-delimited areas of fluid signal on magnetic resonance imaging (MRI), corresponding to radiolucencies encompassed with sclerotic margins on standard radiographs [12, 13] . They are currently gaining increasing attention for their potential etiologic role in the development and progression of OA. Moreover, their presence is associated with increased cartilage loss and risk of knee joint replacement [14] .
The matrix metalloproteinases (MMPs) are a family of 23 proteolytic enzymes that share several structural and functional characteristics with different substrate specificities. MMPs degrade proteins of the extracellular matrix and they have been considered the main enzymes responsible for degradation of collagens in OA cartilage [15] . MMP-1 is an interstitial collagenase that is capable of degrading interstitial collagens (types I, II and III) and is thought to be a multifunctional molecule with important roles in diverse physiologic processes maintaining osteochondral integrity [16, 17] .
In this study, we correlated SBCs presence and MMP-1 expression in different OA stages by using histological and immunohistological measurements, in order: to shed light on SBCs role during the progression of OA and to explore their correlation with MMP-1 expression at the whole cartilagesubchondral bone functional unit.
Our hypothesis was that SBCs might be associated with increased MMP-1 expression.
Patients and methods
Overall, 15 patients aged 60-89 years diagnosed with idiopathic OA of the hip or of the knee in accordance with the criteria of the American College of Rheumatology [18, 19] were included and compared to three controls aged 68-83 years (Table 1 ). Exclusion criteria were as follows: secondary arthritis, haemochromatosis, hip fractures, inflammatory or autoimmune diseases, malignancies, intra-articular administration of steroids. Eight patients suffered of knee OA and seven of hip OA. OA severity was estimated based on pain, functionality, and clinical data using the Harris score for hip OA [20] and the index of severity (ISK) for knee OA [21] . Radiographically, assessment of OA was based on the Ahlback classification for the knee OA [22] and the Kellgren & Lawrence for hip OA [23] . The same orthopaedic surgeon specialized in OA evaluated all X-rays. Controls consisted of three femoral heads [24] [25] [26] [27] , which were harvested in patients undergoing hip hemiarthroplasty following fracture of the femoral neck. All control patients had no known history of bone or joint disease and their cartilage was free of OA lesions (grade 0), according to the Collins scale modified by Muehleman et al. [28] .
Ethical approval and informed consent were received, according to the 1964 Helsinki Declaration.
Histology and immunohistochemistry
We evaluated three specimens per patient, and per control.
Histology
The specimens were fixed in 10% buffered formalin for 24-36 h, decalcified in neutral ethylene-diamine-tetraacetic acid (EDTA) for 6-8 weeks at room temperature, and embedded in paraffin blocks. Three-micrometer thick histological sections were obtained and stained with Haematoxylin/Eosin. The quantitative histological evaluation of the specimens was based on a modified form of the Mankin scale [29, 30] . Normal cartilage was graded as 0, while the scale went up proportionally to the severity of the OA changes. In addition, the status of chondrocytes and the subchondral area were similarly graded. The total score of all parameters characterized the severity of the OA changes in 
Statistical analysis
Kruskal-Wallis test was used for comparing the histological and immunohistochemical evaluation results of the sections between the groups of patients with OA results. Differences were considered significant when P-values were inferior to 0.05.
Results

Subchondral bone cysts and Mankin score in OA
Histological findings were identical for all the noncommunicating cysts, which contained necrotic bone fragments with dead denuclearized cells. The cavities were surrounded by a layer of fibrous connective tissue containing adipocytes and osteoblasts. Overall, the frequency of SBCs was significantly greater in groups III and IV (Fig. 1A) . Specifically, their frequency in patients with knee OA was higher in the group III (Fig. 1B) . Their frequency in patients with hip OA (Fig. 1C) was remarkably increased in group IV (P = 0.028). 
Expression of MMP-1 in OA tissues
Cartilage and subchondral bone matrix and cells, as well as the cystic lesions of OA patients were stained positively for MMP-1, while it was undetectable in controls (Fig. 2) . MMP-1 expression was observed in the sections of the second, third and fourth group and its staining rose significantly with the severity of OA changes. Additionally, the frequency of MMP-1 expression in the cartilage and in the subchondral bone was increased in groups III and IV compared with the groups I and II in both patients with knee (P = 0.03 and P = 0.002, respectively) and hip OA (P = 0.0019 and P = 0.0014, respectively). MMP-1 was detected in the matrix during the aggregation of chondrocytes (Fig. 3A) and in the fibrocartilage (Figs. 3B and C), pannus (Fig. 3D) or fissures (Fig. 4A) . In the subchondral bone, MMP-1 was detected around the osteoblast-like cells (Fig. 4B ) and in the bone-lining cells (Fig. 4B) . The presence of osteoblast-like cells was accompanied by the simultaneous presence of osteoclasts, mainly in group III. However, expression of MMP-1 in the osteoclasts around the cysts was not observed (Fig. 4C) . In group IV there was an increased number of apoptotic osteocytes positive for MMP-1 (Fig. 4D) .
The wall osteoblasts of SBCs in groups III and IV also expressed MMP-1 (Figs. 5 and 6A and B) , whereas MMP-1 expression was not detectable in groups I and II (Fig. 6C) .
Discussion
To the best of our knowledge, this is the first study that examines the relationship between the presence of SBC and MMP-1 expression. Despite the small number of patients in the control group the results reached significance. It is important to note that our observations mostly derived from female patients, reflecting an epidemiological proportion of OA in our region.
The frequency of SBC was related to the severity of the degenerative changes and they were found to develop at the site of greatest disease severity, which is consistent with other studies in humans [31] and in animal models, such as the rat anterior cruciate ligament transection model [3] . It also looks in agreement with the theory of Ondrouch, according to which SBCs appearance is preceded by joint narrowing that would induce subchondral bone micro-fracture in response to repeated overloading.
SBCs were found to coexist with increased cell number of osteoblasts and osteoclasts. Additionally, defects filled by fibrocartilage were observed around the cysts (Fig. 4A ), which were also surrounded by large numbers of apoptotic osteocytes. This suggests incomplete healing following repeated microtrauma, leading to further deterioration and finally to focal osteonecrosis [3] .
Another important finding is the concurrent secretion of MMP-1 in the subchondral bone-lining cells in Mankin stages 6 or more (Fig. 6D) . Although the heterogeneity of their osteoblastic phenotype has been well established, bonelining cells constitute a subpopulation of the osteoblastic family, which responds to abnormal mechanical loading. Before osteoclastic attachment and resorption, bone-lining cells digest non-mineralized collagen protruding from the bone surface, action that would be activated by MMPs [32] .
The SBC osteoblast-like cells showed an increased expression of MMP-1 in Mankin stages greater than 6, which would account for degradation of non-mineralized collagen type I, exposing binding sites on the surface of the bone. This has been shown to be a prerequisite for osteoclast stimulation and attachment to the bone [33] [34] [35] [36] . Our data are in agreement with the study of Sasaki et al. showing that stromal lining cells and osteoblasts would express MMP-1, upon mechanical stimulation, thus preparing recruitment sites for osteoclasts [37] . Furthermore, the presence study showed the coexistence of SBCs with apoptotic osteocytes expressing MMP-1, in late stages of OA. The relationship of MMP-1 with cell apoptosis has been suggested by recent reports providing evidence for the role of MMP-1 in targeting nonmatrix substrates, such as cell bound cytokines, enzymes and cell surface receptors [38] .
These findings have clinical significance and show that SBCs, as well as MMP-1, may be directly involved in the progress of the disease. It has been reported that the presence of SBCs increases the risk of joint replacement [14] and revision arthroplasty [39] . In fact, increased expression of MMP-1 is implicated in the aseptic loosening of joint replacement implants [40] .
Conclusion
In conclusion, MMP-1 expression by osteoblasts, the lining cells of the subchondral bone and SBCs in advanced OA stages, may contribute to the pathological tissue remodelling and the osteochondral changes in OA. Hence, targeting MMP-1 may provide an important therapeutic alternative for OA that affect not only the cartilage but the subchondral bone, as well.
